(1S,2S)-2-(TERT-BUTOXYCARBONYLAMINO) CYCLOHEXANECARBOXYLIC ACID, 95.0%, 5g

(E)-1-(4-(Decyloxy)-3-methylphenyl)-2-(4-(decyloxy)phenyl)diazene, 95% HPLC, 5g

Benzamide, N-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-, 10mg

methyl 2-[2-bromo-4-(trifluoromethyl)phenyl]acetate, 95%, 100mg

tert-Butyl 2-ethyl-4-oxopiperidine-1-carboxylate, 97.0%, 5g

N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95.0%, 5g

2H-Chromene-3-carboxylic acid, 95.0%, 10g

4-Chloro-2-(1,3,4,6,7,8-hexahydro-7,7-dimethyl-1-oxo-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)-3-pyridinecarboxaldehyde, 95+%, 500mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid, 98%, 5g

3,3',3''-((1,3,5-Triazine-2,4,6-triyl)tris(azanediyl))tribenzoic acid, 97%, 500mg

3-(CYCLOHEXYLAMINO)-2-HYDROXY-1-PROPANESULFONIC ACID, 95%, 100g

4-Fluoro-2-nitrobenzoic Acid>98.0%(GC)5g

Bis(2-chlorophenyl)methanol, 95%, 100mg